|
시장보고서
상품코드
2008049
동물용 백신 시장 : 제품 유형별, 용도별, 유통 채널별, 지역별Animal Vaccines Market, By Product Type, By Application, By Distribution Channel, By Geography |
||||||
동물용 백신 시장은 2026년에 98억 1,570만 달러로 추정되고 있으며, 2033년까지 152억 7,560만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 6.6%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 98억 1,570만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년의 예측 기간 CAGR : | 6.60% | 2033년 시장 규모 예측 : | 152억 7,560만 달러 |
동물용 백신은 다양한 수의학 질환의 예방 및 치료에 사용되는 비경구용 제제입니다. 동물용 백신은 반려동물과 가축의 건강 유지, 수명 연장 및 전반적인 생산성 향상에 있으며, 비용 효율적인 방법으로 매우 중요한 역할을 하고 있습니다. 반려동물용 백신은 동물에서 사람으로의 각종 질병 감염을 억제합니다. 이 백신들은 블라스트미세스병, 앵무새병, 고양이 긁힘병 등 다양한 질병의 예방치료에 사용되는 비경구용 제제입니다.
시장 역학
백신은 다양한 질병의 치료를 위한 예방약입니다. 일부 백신은 가격이 비싸서 구입이 어려울 수 있습니다. 따라서 글로벌 동물 백신 시장에서 사업을 운영하는 다양한 기업이 반려동물 백신 접종 비용을 절감하기 위해 반려동물 백신 접종 비용에 대한 환급 제도를 제공하고 있으며, 이는 예측 기간 중 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어 ULTRA Duramune DAP 조합과 Bronchi-Shield ORAL을 투여받은개 환자의 경우, 엘랑코는개 파라인플루엔자 바이러스 감염으로 인한 호흡기 질환 환자의 진단 및 치료와 관련된 통상적이고 관례적인 비용(최대 5,000달러)을 보상합니다. 000 USD)를 보상합니다. 또한 엘랑코는 확진 진단을 위한 표준적이고 합리적인 진단 검사(생검 및 조직병리학적 검사)의 비용도 보상합니다. 확정 진단이 내려진 경우, 엘란코는 표준적이고 합리적인 치료비를 최대 1,500달러까지 보상합니다. "엘랑코는 '울트라 듀라뮨 DAP' 혼합 백신과 'Bronchi-Shield ORAL'을 접종한 반려견 환자의 경우,개 파라인플루엔자 바이러스 감염으로 인한 호흡기 질환을 앓고 있는 환자의 진단 및 치료와 관련된 통상적이고 관례적인 비용(최대 5, 000달러)을 보상합니다. 000 USD)를 보상합니다.
또한 다양한 반려동물 건강 보험회사에서 백신, 검사, 치아 청소, 피임 수술 및 기타 반려동물의 건강과 관련된 활동에 대한 보상을 제공하고 있습니다. 반려동물 건강 보험사로는 ASPCA Pet Insurance, PetFirst Insurance, Embrace Pet Insurance Agency, PetPlan, Allstate Insurance Company 등이 있습니다.
본 조사의 주요 특징.
- 이 보고서는 2020년을 기준연도, 2021년 2028년까지의 예측 기간(2021-2028년)의 세계 동물용 백신 시장 규모에 대한 상세한 분석을 제공합니다.
- 이 보고서는 각 부문의 잠재적 매출 기회를 밝히고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트도 제공합니다.
- 이 보고서는 회사 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등 다양한 매개 변수를 기반으로 세계의 동물 백신 시장의 주요 기업 개요을 작성합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 동물용 백신 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 동물용 백신 시장 : 제품 유형별, 2026-2033년
제5장 세계의 동물용 백신 시장 : 용도별, 2026-2033년
제6장 세계의 동물용 백신 시장 : 유통 채널별, 2026-2033년
제7장 세계의 동물용 백신 시장 : 지역별, 2026-2033년
제8장 경쟁 구도
제9장 섹션
KSAAnimal Vaccines Market is estimated to be valued at USD 9,815.7 Mn in 2026 and is expected to reach USD 15,275.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 9,815.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.60% | 2033 Value Projection: | USD 15,275.6 Mn |
Animal vaccines are parenteral products that are used as prophylactic as well as in the treatment of various veterinary diseases. Animal vaccines play a crucial role in ensuring good health, longevity, and improving overall productivity of pets and livestock, in a cost-effective manner. Companion animal vaccines reduce transmission of various diseases from animals to humans. These vaccines are parenteral products that are used in prophylactic treatment of various diseases such as blastomycosis, psittacosis cat scratch disease, and others.
Market Dynamics
Vaccines are preventive medicines for the treatment of various diseases. Some of the vaccines are expensive to afford. So various companies operating in the global animal vaccines market offer reimbursement to reduce the expenses of pet vaccinations which is expected to augment the market growth over the forecast period. For instance, For canine patients receiving an ULTRA Duramune DAP combination and Bronchi-Shield ORAL, Elanco reimburses normal and customary charges (up to US$ 5,000) associated with the diagnosis and treatment of any patient suffering respiratory disease due to canine parainfluenza virus infection Moreover, Elanco reimburses standard and reasonable diagnostics (a biopsy and histopathological exam) to reach a definitive diagnosis. With a confirmed diagnosis, Elanco reimburses standard and reasonable treatment costs up to US$ 1,500. For canine patients receiving an ULTRA Duramune DAP combination and Bronchi-Shield ORAL, Elanco reimburses normal and customary charges (up to US$ 5,000) associated with the diagnosis and treatment of any patient suffering respiratory disease due to canine parainfluenza virus infection.
Moreover, various pet health insurance companies provide coverage for vaccines, examinations, teeth cleaning, spaying, and other pet health related activities. Some of the pet health insurance companies include ASPCA Pet Insurance, PetFirst Insurance, Embrace Pet Insurance Agency, and PetPlan, Allstate Insurance Company, among others.
Key features of the study
- This report provides an in-depth analysis of the global animal vaccines market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global animal vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies.
- Key companies covered as a part of this study include Merck & Co., Inc., Boehringer Ingelheim International GmbH., Zoetis Inc., Elanco Animal Health Incorporated, Ceva, HIPRA, Romvac Company Sa, Biovac, Vaxxinova International BV, and Biogenesis Bago
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global animal vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global animal vaccines market
Market Segmentation
- By Product Type
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
- By Application
- Companion Animal
- Livestock Animal
- Poultry
- Aquaculture
- By Distribution Channel
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Others
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH.
- Zoetis Inc.
- Elanco Animal Health Incorporated
- Ceva
- HIPRA
- Romvac Company Sa
- Biovac
- Vaxxinova International BV
- Biogenesis Bago
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Drivers and Restraints
- Opportunities
- Impact Analysis
- Key developments
- New Product Launches
- Partnerships and Agreements
- Technological Landscape
- Brand Analysis
- Regulatory Scenario
- Epidemiology
- Reimbursement Schemes
- PORTER Analysis
4. Global Animal Vaccines Market, By Product Type, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2021 and 2032 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Attenuated Live Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Conjugate Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Inactivated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Subunit Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- DNA Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
5. Global Animal Vaccines Market, By Application, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2021 and 2032 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Companion Animal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Livestock Animal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Poultry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Aquaculture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
6. Global Animal Vaccines Market, By Distribution Channel, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2021 and 2032 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Veterinary Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Veterinary Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Veterinary Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
7. Global Animal Vaccines Market, By Region, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2021 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country 2026 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Zoetis Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Elanco Animal Health Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ceva
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- HIPRA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Romvac Company Sa
- Company Highlights
- Product Portfolio
- Key Highlights
- Strategies
- Biovac
- Company Highlights
- Product Portfolio
- Key Highlights
- Strategies
- Vaxxinova International BV
- Company Highlights
- Product Portfolio
- Key Highlights
- Strategies
- Biogenesis Bago
- Company Highlights
- Product Portfolio
- Key Highlights
- Strategies
- Merck & Co., Inc.
9. Section
- Research Methodology
- About Us
